ES2061786T3 - Solucion de antigeno que contiene una poli(alfaolefina (pao)), procedimiento para su preparacion y la utilizacion de pao como coadyuvante. - Google Patents

Solucion de antigeno que contiene una poli(alfaolefina (pao)), procedimiento para su preparacion y la utilizacion de pao como coadyuvante.

Info

Publication number
ES2061786T3
ES2061786T3 ES89109127T ES89109127T ES2061786T3 ES 2061786 T3 ES2061786 T3 ES 2061786T3 ES 89109127 T ES89109127 T ES 89109127T ES 89109127 T ES89109127 T ES 89109127T ES 2061786 T3 ES2061786 T3 ES 2061786T3
Authority
ES
Spain
Prior art keywords
pao
alphaolefine
coadjuvant
poly
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89109127T
Other languages
English (en)
Inventor
Dieter Dr Bernhardt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2061786T3 publication Critical patent/ES2061786T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBE UN PROCESO DE COMPLEMENTACION DE SOLUCIONES ANTIGENAS, DONDE SE EMULSIONA UNA SOLUCION ANTIGENA CON UNA POLIALFAOLEFINA ("HIGHLY BRANCHED ISOPARAFFIN POLYALPHAOLEFIN") Y UN EMULGADOR.
ES89109127T 1988-05-24 1989-05-20 Solucion de antigeno que contiene una poli(alfaolefina (pao)), procedimiento para su preparacion y la utilizacion de pao como coadyuvante. Expired - Lifetime ES2061786T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3817531A DE3817531A1 (de) 1988-05-24 1988-05-24 Antigenloesung enthaltend ein polyalphaolefin (pao), verfahren ihrer herstellung und die verwendung von pao als adjuvans

Publications (1)

Publication Number Publication Date
ES2061786T3 true ES2061786T3 (es) 1994-12-16

Family

ID=6354974

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89109127T Expired - Lifetime ES2061786T3 (es) 1988-05-24 1989-05-20 Solucion de antigeno que contiene una poli(alfaolefina (pao)), procedimiento para su preparacion y la utilizacion de pao como coadyuvante.

Country Status (4)

Country Link
EP (1) EP0343548B1 (es)
AT (1) ATE98494T1 (es)
DE (2) DE3817531A1 (es)
ES (1) ES2061786T3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4007315A1 (de) * 1990-03-08 1991-09-12 Behringwerke Ag Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen
FR3092754B1 (fr) * 2019-02-18 2022-06-03 Total Marketing Services Composition adjuvante pour vaccin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446515A1 (de) * 1984-12-20 1986-06-26 Behringwerke Ag, 3550 Marburg Oeladjuvierte vaccine und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0343548A2 (de) 1989-11-29
DE3817531A1 (de) 1989-12-07
EP0343548A3 (en) 1990-05-09
DE58906400D1 (de) 1994-01-27
EP0343548B1 (de) 1993-12-15
ATE98494T1 (de) 1994-01-15

Similar Documents

Publication Publication Date Title
ES2032397T3 (es) Procedimiento para preparar una composicion en dispersion solida de la sustancia fr-900506
TW275578B (es)
AU2737888A (en) One step dressing delivery system
ES2022886B3 (es) Conjunto de dispositivos luminosos para un sistema de tratamiento de pacientes por fotoactivacion.
FR2714599B1 (fr) Composition pour lutter contre le vieillissement, agissant siimultanément sur les couches superficielles et profondes de la peau, son utilisation.
DE69721458T2 (de) Ausrüstung enthaltend eine implantierbare Vorrichtung
FI931916A (fi) Transdermala befruktningshindrande formuleringar, metoder och anordningar
NO954186L (no) Plaster med aktive bestanddeler
ATE147262T1 (de) Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung
AU4844890A (en) Method and apparatus for the rapid thawing of cryopreserved blood, blood components, and tissue
CA2071981A1 (en) The use of gaba-b selective agonists as anti-tussive agents
FI872908A0 (fi) Haorspaenne och dess anvaendningsfoerfarande.
ES2057291T3 (es) Procedimiento para la preparacion de 23-(alquilc1-c6 oxima)ll-f28249.
AU7422287A (en) Intravaginal devices
DE69531793D1 (de) Immunogene zubereitungen
ES2169779T3 (es) Procedimiento para la preparacion de poli(diorganosiloxanos), composiciones que contienen los mismos y su uso.
FI894804A (fi) Anvaendning av zink- och jaernhydroxid som adjuvanter av antigenloesningar och pao detta saett effektiverade antigenloesningar.
ES2061786T3 (es) Solucion de antigeno que contiene una poli(alfaolefina (pao)), procedimiento para su preparacion y la utilizacion de pao como coadyuvante.
GR79300B (es)
ES2038393T3 (es) Procedimiento para la preparacion de un sistema de aplicacion intravaginal.
ES2018796B3 (es) Procedimiento para obtener un agente conservador de la madera
SE8500845L (sv) Forfarande for framstellning av glyoxylylspermidin och anvendningen derav for framstellning av 15-deoxispergualin-beslektade foreningar
DK0659080T3 (da) Fremgangsmåde til behandling af hårtab
NO158984C (no) Anvendelse av (e)-beta-farnesen i vaeskeform eller av en (e)-beta-farnesen-inneholdende vaeske som et kontaktinsekticidmot bladlus.
BR8701478A (pt) Mistura de aclaradores oticos,aplicacao e agente para o aclaramento otico de fibras

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 343548

Country of ref document: ES